We are live on ! Find out more
THRN

Thorne Healthtech, Inc. Common Stock

Delisted

THRN was delisted on the 13th of October, 2023.

44 hedge funds and large institutions have $26.2M invested in Thorne Healthtech, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less capital invested

Capital invested by funds: $26.7M → $26.2M (-$462K)

10% less funds holding

Funds holding: 4944 (-5)

11% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 18

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

Holders
44
Holders Change
-5
Holders Change %
-10.2%
% of All Funds
0.76%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
16
Reduced
18
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AWS
26
Atria Wealth Solutions
New York
$48.2K -$101K -20,000 -66%
Deutsche Bank
27
Deutsche Bank
Germany
$40K -$4.6K -916 -10%
JP Morgan Chase
28
JP Morgan Chase
New York
$35K
Barclays
29
Barclays
United Kingdom
$34K -$538 -107 -1%
AIG
30
American International Group
New York
$31K +$462 +92 +1%
Allspring Global Investments
31
Allspring Global Investments
North Carolina
$28K +$30.5K +6,077 New
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$26K -$2.27K -452 -8%
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$16K +$15.5K +3,089 +1,735%
BNP Paribas Financial Markets
34
BNP Paribas Financial Markets
France
$13.7K +$14.6K +2,905 New
TRCT
35
Tower Research Capital (TRC)
New York
$13K -$22.3K -4,438 -62%
AB
36
Amalgamated Bank
New York
$9K +$166 +33 +2%
US Bancorp
37
US Bancorp
Minnesota
$9K +$10.1K +2,000 New
Legal & General Group
38
Legal & General Group
United Kingdom
$7K -$955 -190 -12%
AIP
39
Ameritas Investment Partners
Nebraska
$2K
Fidelity Investments
40
Fidelity Investments
Massachusetts
$2K +$2.59K +515 +51,500%
Citigroup
41
Citigroup
New York
$1K -$4.09K -814 -79%
Wells Fargo
42
Wells Fargo
California
$1K -$498 -99 -29%
Millennium Management
43
Millennium Management
New York
-$336K -69,450 Closed
MA
44
MYDA Advisors
New York
-$334K -69,000 Closed
Citadel Advisors
45
Citadel Advisors
Florida
-$121K -24,974 Closed
Jane Street
46
Jane Street
New York
-$100K -20,701 Closed
TI
47
Trexquant Investment
Connecticut
-$99K -20,475 Closed
Acadian Asset Management
48
Acadian Asset Management
Massachusetts
-$36K -7,369 Closed
UBS Group
49
UBS Group
Switzerland
-$8K -1,652 Closed
PNC Financial Services Group
50
PNC Financial Services Group
Pennsylvania
-$5K -1,000 Closed

THRN Hedge Fund Activity: Q3 2022 in Review

44 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Thorne Healthtech, Inc. Common Stock (THRN) for Q3 2022, worth a combined $26.2M — down 1.7% from $26.7M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of THRN and 4 opened new positions — a net loss of 5 holders — while 18 trimmed existing stakes and 16 added.

The largest buyer was Vanguard Group, adding an estimated $1.56M. The largest seller was Millennium Management, exiting entirely with an estimated $336K sold.

  • 44 institutional investors held Thorne Healthtech, Inc. Common Stock (THRN) as of Q3 2022, down from 49 in Q2 2022.
  • Funds reported $26.2M of Thorne Healthtech, Inc. Common Stock stock for Q3 2022, down 1.7% quarter-over-quarter.
  • 4 funds opened new Thorne Healthtech, Inc. Common Stock positions in Q3 2022 and 9 closed out, a net change of -5 holders.
  • The largest Thorne Healthtech, Inc. Common Stock buyer in Q3 2022 was Vanguard Group, an estimated $1.56M added.
  • The largest Thorne Healthtech, Inc. Common Stock seller in Q3 2022 was Millennium Management, an estimated $336K sold.

Based on aggregated 13F filings for Q3 2022.